Effect of CT-Guided Repeated Pulsed Radiofrequency on Controlling Acute/Subacute Zoster-Associated Pain: A Retrospective Cohort Study

Pain and Therapy - Trang 1-14 - 2023
Min Rui1, Zixin Han1, Longsheng Xu1, Ming Yao1
1Department of Anesthesiology and Pain Research Center, The Affiliated Hospital of Jiaxing University, Jiaxing, China

Tóm tắt

Zoster-associated pain (ZAP) treatment and management is still inadequate. Repeated intervention protocol is often applied to manage ZAP. This study aimed to retrospectively investigate the effect of repeated applications of pulsed radiofrequency therapy on controlling acute/subacute ZAP. From March 2019 to December 2021, 150 patients with acute/subacute ZAP who underwent repeated application of pulsed radiofrequency treatment (R-PRF) and pulsed radiofrequency combined paravertebral block interventions (PRF + PVB) in the Pain Department of the affiliated Hospital of Jiaxing University were enrolled. Patients were grouped by intervention protocol and received at least 12 months of follow-up assessments using the Numerical Rating Scale score (NRSs), Pittsburg Sleep Quality Index (PSQI), Simple McGill Pain Questionnaire-2 score (SF-MPQ-2s), and follow-up interventions. Both groups experienced a reduction in the incidence of clinically meaningful ZAP after the intervention therapy. In the R-PRF group, there were 36 cases of clinically meaningful ZAP within the first month post-treatment, while the PRF + PVB group had 38 cases. The incidence of clinically meaningful ZAP, as determined by multivariable generalized estimating equations, was 42.86% in the R-PRF group and 57.58% in the PRF + PVB group during the first month of follow-up. There was a significant difference in the incidence of clinically meaningful ZAP between the two groups after 1 month of treatment (adjusted odds ratio: 0.40; 95% confidence interval: 0.18–0.91; p = 0.03). Both R-PRF and PRF + PVB treatments effectively relieve pain in patients with acute/subacute ZAP. However, R-PRF may have superior efficacy compared to PRF + PVB in reducing the incidence of clinically meaningful ZAP 1 month after treatment.

Tài liệu tham khảo

Bricout H, Haugh M, Olatunde O, et al. Herpes zoster-associated mortality in Europe: a systematic review. BMC Public Health. 2015;15(1):1–14. Johnson RW, Alvarez-Pasquin MJ, Bijl M, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015;3(4):109–20. Johnson RW. Zoster-associated pain: what is known, who is at risk and how can it be managed? Herpes. 2007;14(Suppl 2):30–4. Forbes HJ, Thomas SL, Smeeth L, et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157(1):30–54. Gabutti G, Valente N, Kuhdari P, et al. Prevention of herpes zoster and its complications: from the clinic to the real-life experience with the vaccine. J Med Microbiol. 2016;65(12):1363–9. Luo G, Zhang Z, Zhu J, et al. Association between the risk of relapse and the type of surgical procedure for herpes zoster-related pain. Pain Physician. 2021;24(8):E1227–36. Forbes HJ, Bhaskaran K, Thomas SL, et al. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients. Neurology. 2016;87(1):94–102. Chen L, Li J, Liu H, et al. Interventions for zoster-associated pain: a retrospective study based on the clinical database. Front Neurol. 2022;13:1056171. Kim ED, Lee YI, Park HJ. Comparison of efficacy of continuous epidural block and pulsed radiofrequency to the dorsal root ganglion for management of pain persisting beyond the acute phase of herpes zoster. PLoS ONE. 2017;12(8): e0183559. Ji G, Niu J, Shi Y, et al. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg. 2009;109(5):1651–5. Ma K, Fan YH, Jin Y, et al. Efficacy of pulsed radiofrequency in the treatment of thoracic postherpetic neuralgia from the angulus costae: a randomized, double-blinded, controlled trial. Pain Physician. 2013;16(1):15–25. Li D, Sun G, Sun H, et al. Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial. PeerJ. 2018;6: e4852. Arons M, Pilmane M, Vasilevskis E, et al. Morphological changes in the lumbar dorsal root ganglion of the domestic porcine after pulsed radiofrequency stimulation. Anesteziol Reanimatol. 2013;4:26–30. Vallejo R, Tilley D, Williams J, et al. Pulsed radiofrequency modulates pain regulatory gene expression along the nociceptive pathway. Pain Physician. 2013;16:E601-613. Van Zundert J, de Louw AJ, Joosten EA, et al. Pulsed and continuous radiofrequency current adjacent to the cervical dorsal root ganglion of the rat induces late cellular activity in the dorsal horn. Anesthesiology. 2005;102(1):125–31. Makharita MY, Amr YM, El-Bayoumy Y. Single paravertebral injection for acute thoracic herpes zoster: a randomized controlled trial. Pain Pract. 2015;15(3):229–35. Kim HJ, Ahn HS, Lee JY, et al. Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean J Pain. 2017;30(1):3–17. Richardson J. Paravertebral anesthesia and analgesia. Can J Anesth. 2004;51(Suppl 1):R6. Johansson A, Bennett GJ. Effect of local methylprednisolone on pain in a nerve injury model: a pilot study. Reg Anesth Pain Med. 1997;22(1):59–65. Devor M, Govrin-Lippmann R, Raber P. Corticosteroids suppress ectopic neural discharge originating in experimental neuromas. Pain. 1985;22(2):127–37. Hayashi H, Yonemoto N, Hayashi F, et al. Distal approaches of ultrasound-guided intercostal nerve block in patients with acute zoster-associated pain: a quantitative descriptive research. Reg Anesth Pain Med. 2023;48(Suppl 1):A218–A218. Liu L, Zhang W-J, Xu S-X, et al. Propensity score matching comparing short-term nerve electrical stimulation to pulsed radiofrequency for herpes zoster-associated pain: a retrospective study. Front Mol Neurosci. 2022;15:1068. Coplan PM, Schmader K, Nikas A, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5(6):344–56. Lydick E, Epstein RS, Himmelberger D, et al. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology. 1995;45(12 Suppl 8):S52–3. Oxman MN, Levin MJ, Johnson G, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–84. Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009;144(1–2):35–42. Ding Y, Li H, Hong T, et al. Efficacy and safety of computed tomography-guided pulsed radiofrequency modulation of thoracic dorsal root ganglion on Herpes Zoster neuralgia. Neuromodulation. 2019;22(1):108–14. Makharita MY, Amr YM. Effect of repeated paravertebral injections with local anesthetics and steroids on prevention of post-herpetic neuralgia. Pain Physician. 2020;23(6):565–72. Zhang E, Fei Y, Xu L, et al. Effect of repeated high-voltage long-duration pulsed radiofrequency on herpetic neuralgia. Pain Physician. 2022;25(7):E1047–55. Peng ZY, Guo JG, Zhang YF, et al. Development of a model for predicting the effectiveness of pulsed radiofrequency on Zoster-associated pain. Pain Ther. 2022;11(1):253–67. Irwin MR, Opp MR. Sleep health: reciprocal regulation of sleep and innate immunity. Neuropsychopharmacology. 2017;42(1):129–55. Irwin MR, Witarama T, Caudill M, et al. Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain Behav Immun. 2015;47:86–92. Irwin MR, Wang M, Campomayor CO, et al. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006;166(16):1756–62. Irwin MR, Wang M, Ribeiro D, et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry. 2008;64(6):538–40. Irwin MR. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol. 2019;19(11):702–15. Couzin-Frankel J. Inflammation bares a dark side. Science. 2010;330(6011):1621.